Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Bispecific | 3 | 2024 | 191 | 1.120 |
Why?
|
Multiple Myeloma | 11 | 2024 | 5129 | 1.090 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 179 | 0.740 |
Why?
|
Paraproteinemias | 1 | 2023 | 246 | 0.720 |
Why?
|
Kidney Diseases | 1 | 2023 | 2083 | 0.400 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2024 | 39 | 0.230 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 231 | 0.210 |
Why?
|
Scurvy | 1 | 2001 | 35 | 0.190 |
Why?
|
Thalidomide | 1 | 2024 | 884 | 0.160 |
Why?
|
Oligopeptides | 1 | 2024 | 1185 | 0.160 |
Why?
|
Renal Insufficiency | 1 | 2024 | 809 | 0.150 |
Why?
|
Hematology | 1 | 2021 | 241 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 259 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 349 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1454 | 0.140 |
Why?
|
Dexamethasone | 1 | 2024 | 1927 | 0.140 |
Why?
|
Cerebellum | 2 | 2013 | 1497 | 0.130 |
Why?
|
Thrombocytopenia | 1 | 2022 | 1171 | 0.120 |
Why?
|
Thimerosal | 1 | 2012 | 15 | 0.100 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2012 | 34 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1402 | 0.100 |
Why?
|
Lipopolysaccharides | 2 | 2022 | 2204 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1890 | 0.090 |
Why?
|
Thyroid Hormones | 1 | 2012 | 403 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10171 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3364 | 0.080 |
Why?
|
Kidney | 1 | 2023 | 7016 | 0.070 |
Why?
|
Humans | 18 | 2024 | 758406 | 0.060 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2013 | 3099 | 0.060 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 80 | 0.060 |
Why?
|
Tissue Extracts | 1 | 2024 | 140 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11709 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7378 | 0.050 |
Why?
|
Rats, Inbred SHR | 2 | 2013 | 186 | 0.050 |
Why?
|
B-Cell Maturation Antigen | 1 | 2023 | 148 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13591 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2685 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2024 | 778 | 0.050 |
Why?
|
Ethanol | 1 | 2007 | 1323 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 580 | 0.050 |
Why?
|
Spinal Puncture | 1 | 2022 | 281 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2496 | 0.050 |
Why?
|
Phenylalanine | 1 | 2021 | 365 | 0.040 |
Why?
|
Melphalan | 1 | 2021 | 420 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2022 | 294 | 0.040 |
Why?
|
Videoconferencing | 1 | 2021 | 203 | 0.040 |
Why?
|
Remission Induction | 1 | 2024 | 2388 | 0.040 |
Why?
|
Species Specificity | 2 | 2013 | 2417 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4641 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2001 | 655 | 0.040 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 617 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2013 | 2672 | 0.040 |
Why?
|
Femoral Fractures | 1 | 2001 | 375 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 7985 | 0.040 |
Why?
|
Cancer Vaccines | 1 | 2024 | 1046 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1887 | 0.030 |
Why?
|
Atherectomy, Coronary | 1 | 1995 | 142 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3099 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18119 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2895 | 0.030 |
Why?
|
Drug Discovery | 1 | 2021 | 1044 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2796 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2532 | 0.030 |
Why?
|
Biological Products | 1 | 2021 | 906 | 0.030 |
Why?
|
Radiography | 2 | 2001 | 6954 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2013 | 8143 | 0.020 |
Why?
|
Male | 8 | 2024 | 358747 | 0.020 |
Why?
|
United States | 3 | 2024 | 72136 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2012 | 294 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2012 | 493 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9574 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11892 | 0.020 |
Why?
|
Motor Skills | 1 | 2012 | 519 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 543 | 0.020 |
Why?
|
Neurons | 1 | 2007 | 9416 | 0.020 |
Why?
|
Female | 6 | 2024 | 390323 | 0.020 |
Why?
|
Transcription Factors | 1 | 2007 | 12094 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 1432 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64378 | 0.020 |
Why?
|
Aged | 3 | 2024 | 168218 | 0.020 |
Why?
|
Rats | 2 | 2013 | 23679 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 219568 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9273 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 1995 | 2189 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2013 | 1401 | 0.020 |
Why?
|
Adult | 3 | 2024 | 219935 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 18940 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4777 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 80168 | 0.010 |
Why?
|
Animals | 4 | 2024 | 167768 | 0.010 |
Why?
|
Stents | 1 | 1995 | 3162 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1739 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2012 | 2621 | 0.010 |
Why?
|
Pregnancy | 2 | 2013 | 29742 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10504 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7583 | 0.010 |
Why?
|
Stem Cells | 1 | 2012 | 3521 | 0.010 |
Why?
|
Infant | 1 | 2001 | 36055 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10748 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 1995 | 6362 | 0.010 |
Why?
|
Child | 1 | 2022 | 79818 | 0.010 |
Why?
|
Mice | 2 | 2012 | 81101 | 0.010 |
Why?
|
Angina Pectoris | 1 | 1995 | 958 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22003 | 0.010 |
Why?
|
Recurrence | 1 | 1995 | 8426 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1995 | 11424 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1995 | 39059 | 0.000 |
Why?
|
Concepts
(109)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_